Environmental determinants: The role of viruses and standard of hygiene

Epidemiology of Pediatric and Adolescent Diabetes

Volumn , Issue , 2008, Pages 63-84

  Knip, Mikael ^a,b   Hyöty, Heikki ^b,c  

^a UNIVERSITY OF HELSINKI   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84856306936     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (127)

1. Knip M, Veijola R, Virtanen SM, et al. Environmental triggers and determinants of b-cell autoimmunity and type 1 diabetes. Diabetes 2005; 54(suppl 2):S125-S136.
2. Ilonen J, Sjöroos M, Knip M, et al. Estimation of genetic risk for type 1 diabetes. Am J Med Genet 2002; 115:30-36.
3. Dahlquist G. Environmental risk factors in human Type 1 diabetes: an epidemiological perspective. Diabetes Metab Rev 1995; 11:37-46.
4. Akerblom HK, Knip M. Putative environmental factors in type 1 diabetes. Diabetes Metab Rev 1998; 14:31-67.
5. Akerblom HK, Vaarala O, Hyöty H, et al. Environmental factors in the etiology of type 1 diabetes. Am J Med Genet 2002; 115:18-29.
6. Knip M. Natural course of preclinical type 1 diabetes. Horm Res 2002; 57(suppl 1):6-11.
7. Knip M. Can we predict type 1 diabetes in the general population? Diabetes Care 2002; 25:623-625.
8. Ziegler AG, Hummel M, Schenker M, et al. Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study. Diabetes 1999; 48:460-468.
9. Kimpimäki T, Kupila A, Hämäläinen AM, et al. The first signs of β-cell autoimmunity appear in infancy in genetically susceptible children from the general population: the Finnish Type 1 diabetes prediction and prevention study. J Clin Endocrinol Metab 2001; 86:4782-4788.
10. Kukko M, Kimpimäki T, Korhonen S, et al. Dynamics of diabetes-associated autoantibodies in young children with HLA-conferred risk of type 1 diabetes recruited from the general population. J Clin Endocrinol Metab 2005; 90:2712-2717.
11. Kupila A, Muona P, Ronkainen M, et al. Genetic risk determines the emergence of diabetes-associated autoantibodies in young children. Diabetes 2002; 51:646-651.
12. Mrena S, Virtanen S, Laippala P, et al. Models for predicting type 1 diabetes in siblings of affected children. Diabetes Care 2006; 29:662-667.
13. Kimpimäki T, Kulmala P, Savola K, et al. Disease-associated autoantibodies as surrogate markers of type 1 diabetes in young children at increased genetic risk. J Clin Endocrinol Metab 2000; 85:1126-1130.
14. Leslie RD, Delli Castelli M. Age-dependent influences on the origins of autoimmune diabetes: evidence and implications. Diabetes 2004; 53:3033-3040.
15. Alaedini A, Green PH. Narrative review: celiac disease: understanding a complex autoimmune disorder. Ann Intern Med 2005; 142:289-298.
16. Mäki M, Mustalahti K, Kokkonen J, et al. Prevalence of celiac disease in children in Finland. N Engl J Med 2003; 348:2517-2524.
17. Kagnoff MF, Paterson YJ, Kumar PJ, et al. Evidence for the role of human intestinal adenovirus in the pathogenesis of celiac disease. Gut 1987; 28:995-1001.
18. Lähdeaho ML, Parkkonen P, Reunala T, et al. Antibodies to the E1bprotein-derived peptides of enteric adenovirus type 40 are associated with celiac disease and dermatitis herpetiformis. Clin Immunol Immunopathol 1993; 69:300-305.
19. Stene LC, Honeyman MC, Hoffenberg EJ, et al. Rotavirus infection frequency and risk of celiac disease autoimmunity in early childhood: a longitudinal study. Am J Gastroenterol 2006; 101:2333-2334.
20. HyotyH, Taylor KW. The role of viruses in human diabetes. Diabetologia 2002; 45:1353-1361.
21. Yoon JW. Role of viruses in the pathogenesis of IDDM. Ann Med 1991; 23:437-445.
22. Szopa TM, Titchener PA, Portwood ND, et al. Diabetes mellitus due to viruses-some recent developments. Diabetologia 1993; 36:687-695.
23. Barrett-Connor E. Is insulin-dependent diabetes mellitus caused by Coxsackie B infection? A review of the epidemiologic evidence. Rev Infect Dis 1985; 7:207-215.
24. Banatvala JE. Insulin-dependent (juvenile-onset, type 1) diabetes mellitus. Coxsackie B viruses revisited. Prog Med Virol 1987; 34:33-54.
25. Gamble DR, TaylorKW. Seasonal incidence of diabetesmellitus. Br Med J 1969; 3: 631-633.
26. Orchard TJ, Atchison RW, Becker D, et al. Coxsackie infection and diabetes. Lancet 1983; 2:631.
27. Mertens T, Grü neklee D, Eggers HJ. Neutralizing antibodies against Coxsackie B viruses in patients with recent onset of type 1 diabetes. Eur J Pediatr 1983; 140:293-294.
28. Palmer JP, Cooney MK, Ward RH, et al. Reduced Coxsackie antibody titres in Type 1 (insulin-dependent) diabetic patients presenting during an outbreak of Coxsackie B3 and B4 infection. Diabetologia 1982; 22:426-429.
29. Graves PM, Norris JM, Pallansch MA, et al. The role of enteroviral infections in the development of IDDM: limitations of current approaches. Diabetes 1997; 46:161-168.
30. Frisk G, Fohlman J, Kobbah M, et al. High frequency of Coxsackie-B-virus-specific IgM in children developing type 1 diabetes during a period of high diabetes morbidity. J Med Virol 1985; 17:219-227.
31. Fohlman J, Friman G. Is juvenile diabetes a viral disease? Ann Med 1993; 25:569-574.
32. Nerup J, Mandrup-Poulsen T, Mølvig J, et al. Mechanisms of pancreatic beta-cell destruction in Type 1 diabetes. Diabetes Care 1988; 11(suppl 1):16-23.
33. Clements GB, Galbraith DN, Taylor KW. Coxsackie B virus infection and onset of childhood diabetes. Lancet 1995; 346:221-223.
34. Foy CA, Quirke P, Lewis FA, et al. Detection of common viruses using the polymerase chain reaction to assess levels of viral presence in type 1 (insulin-dependent) diabetic patients. Diabet Med 1995; 12:1002-1008.
35. Andreoletti L, Hober D, Hober-Vandenberghe C, et al. Detection of coxsackie B virus RNA sequences in whole blood samples from adult patients at the onset of type I diabetes mellitus. J Med Virol 1997; 52:121-127.
36. Nairn C, Galbraith DN, Taylor KW, et al. Enterovirus variants in the serum of children at the onset of Type 1 diabetes mellitus. Diabet Med 1999; 16:509-513.
37. Chehadeh W, Weill J, Vantyghem MC, et al. Increased level of interferon-alpha in blood of patients with insulin-dependent diabetes mellitus: relationship with coxsackievirus B infection. J Infect Dis 2000; 181:1929-1939.
38. Yin H, Berg AK, Tuvemo T, et al. Enterovirus RNA is found in peripheral blood mononuclear cells in a majority of type 1 diabetic children at onset. Diabetes 2002; 51:1964-1971.
39. Craig ME, Howard NJ, Silink M, et al. Reduced frequency of HLA DRB1β03-DQB1β02 in children with type 1 diabetes associated with enterovirus RNA. J Infect Dis 2003; 187:1562-1570.
40. Kawashima H, Ihara T, Ioi H, et al. Enterovirus-related type 1 diabetes mellitus and antibodies to glutamic acid decarboxylase in Japan. J Infect 2004; 49:147-151.
41. Moya-Suri V, Schlosser M, Zimmermann K, et al. Enterovirus RNA sequences in sera of schoolchildren in the general population and their association with type 1-diabetesassociated autoantibodies. J Med Microbiol 2005; 54:879-883.
42. Sarmiento L, Cabrera-Rode E, Lekuleni L, et al. Occurrence of enterovirus RNA in serum of children with newly diagnosed type 1 diabetes and islet cell autoantibodypositive subjects in a population with a low incidence of type 1 diabetes. Autoimmunity 2007; 40:540-545.
43. Elfaitouri A, Berg AK, Frisk G, et al. Recent enterovirus infection in type 1 diabetes: evidence with a novel IgM method. J Med Virol 2007; 79:1861-1867.
44. Hyöty H, Hiltunen M, Knip M, et al. A prospective study of the role of Coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Diabetes 1995; 44:652-657.
45. Hiltunen M, Hyöty H, Knip M, et al. ICA seroconversion in children is temporally associated with enterovirus infections. J Infect Dis 1997; 175:554-560.
46. Lönnrot M, Salminen K, Knip M, et al. Enterovirus RNA in serum is a risk factor for beta-cell autoimmunity and clinical type 1 diabetes: a prospective study. J Med Virol 2000; 61:214-220.
47. Lönnrot M, Korpela K, Knip M, et al. Enterovirus infection as a risk factor for β-cell autoimmunity in a prospectively observed birth cohort-the Finnish Diabetes Prediction and Prevention (DIPP) study. Diabetes 2000; 49:1314-1318.
48. Salminen K, Sadeharju K, Lönnrot M, et al. Enterovirus infections are associated with the induction of beta-cell autoimmunity in a prospective birth cohort study. J Med Virol 2003; 69:91-98.
49. Fuchtenbusch M, Irnstetter A, Jager G, et al. No evidence for an association of coxsackie virus infections during pregnancy and early childhood with development of islet autoantibodies in offspring of mothers or fathers with type 1 diabetes. J Autoimmun 2001; 17:333-340.
50. Graves PM, Rotbart HA, Nix WA, et al. Prospective study of enteroviral infections and development of beta-cell autoimmunity. Diabetes autoimmunity study in the young (DAISY). Diabetes Res Clin Pract 2003; 59:51-61.
51. Dahlquist CG, Ivarsson S, Lindberg B, et al. Maternal enteroviral infection during pregnancy. Diabetes 1995; 44:408-413.
52. Viskari HR, Roivainen M, Reunanen A, et al. Maternal first-trimester enterovirus infection and future risk of type 1 diabetes in the exposed fetus. Diabetes 2002; 51: 2568-2571.
53. Oikarinen M, Tauriainen S, Honkanen T, et al. Detection of enteroviruses in the intestine of type 1 diabetic patients. Clin Exp Immunol 2007; DOI: 10.1111/j.1365-2249.2007.03529.x.
54. SzopaTM, Ward T, DronfieldDM, et al. Coxsackie B4 viruses with the potential to damage beta cells of the islets are present in clinical isolates. Diabetologia 1990; 33: 325-328.
55. Roivainen M, Rasilainen S, Ylipaasto P, et al. Mechanisms of coxsackievirus-induced damage to human pancreatic beta-cells. J Clin Endocrinol Metab 2000; 85:432-440.
56. Roivainen M, Ylipaasto P, Savolainen C, et al. Functional impairment and killing of human beta cells by enteroviruses: the capacity is shared by a wide range of serotypes, but the extent is a characteristic of individual virus strains. Diabetologia 2002; 45: 693-702.
57. Gladisch R, Hofmann W, Waldherr R. Myocarditis and insulitis following coxsackie virus infection. Z Kardiol 1976; 65:837-849.
58. Yoon JW, Austin M, Onodera T, et al. Isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N Engl J Med 1979; 300:1173-1179.
59. Iwasaki T, Monma N, Satodate R, et al. An immunofluorescent study of generalized Coxsackie virus B3 infection in a newborn infant. Acta Pathol Jpn 1985; 35:741-748.
60. Foulis AK, Farquharson MA, Cameron SO, et al. A search for the presence of the enteroviral capsid protein VP1 in pancreases of patients with type 1 (insulin-dependent) diabetes and pancreases and hearts of infants who died of coxsackie viral myocarditis. Diabetologia 1990; 33:290-298.
61. Foulis AK, McGill M, Farquharson MA, et al. A search for evidence of viral infection in pancreases of newly diagnosed patients with IDDM. Diabetologia 1997; 40:53-61.
62. Ylipaasto P, Klingel K, Lindberg AM, et al. Enterovirus infection in human pancreatic islet cells, islet tropism in vivo and receptor involvement in cultured islet beta cells. Diabetologia 2004; 47:225-239.
63. Dotta F, Censini A, van Halteren A, et al. Coxsackie B4 virus infection of beta cells and natural killer cell insulitis in recent-onset type 1 diabetic patients. Proc Natl Acad Sci U S A 2007; 104:5115-5120.
64. Kupila A, Muona P, Simell T, et al. Feasibility of genetic and immunological prediction of type 1 diabetes in a population-based birth cohort. Diabetologia 2001; 44:290-297.
65. Laron Z. Lessons from recent epidemiological studies in type 1 childhood diabetes. J Pediatr Endocrinol Metab 1999; 12(suppl 3):733-736.
66. Kukko M, Toivonen A, Kupila A, et al. Familial clustering of beta-cell autoimmunity in initially non-diabetic children. Diabetes Metab Res Rev 2006; 22:53-58.
67. Karvonen M, Viik-Kajander M, Moltchanova E, et al. Incidence of childhood type 1 diabetes worldwide. Diabetes Care 2000; 23:1516-1526.
68. The EURODIAB Substudy 2 Study Group: vitamin D supplement in early childhood and risk of Type I (insulin-dependent) diabetes mellitus. Diabetologia 1999; 42:51-54.
69. Hyppönen E, Läärä E, Järvelin MR, et al. Intake of vitamin D and risk of type 1 diabetes: a birth cohort study. Lancet 2001; 358:1500-1504.
70. Kondrashova A, Reunanen A, Romanov A, et al. A sixfold gradient in the incidence of type 1 diabetes at the eastern border of Finland-evidence for the role of environmental factors in the disease pathogenesis. Ann Med 2005; 37:67-72.
71. Viskari H, Kondrashova A, Koskela P, et al. Circulating vitamin D concentrations in two neighboring populations with markedly different incidence of type 1 diabetes. Diabetes Care 2006; 49:1458-1459.
72. Käär ML, Akerblom HK, Huttunen NP, et al. Metabolic control of children and adolescents with insulin-dependent diabetes mellitus. Acta Paediatr Scand 1984; 73:102-108.
73. Hinde FR, Standen PJ, Mann NP, et al. Seasonal variation of haemoglobin A1 in children with insulin-dependent diabetes mellitus. Eur J Pediatr 1989; 148:146-147.
74. Nordfeldt S, Ludvigsson J. Seasonal variation of HbA1c in intensive treatment of children with type 1 diabetes. J Pediatr Endocrinol Metab 2000; 13:529-535.
75. Dahlquist G. Environmental factors and type 1 diabetes. Diabetes Care 2001; 24:80-182.
76. Viskari H, Ludvigsson J, Uibo R, et al. Relationship between the incidence of type 1 diabetes and maternal enterovirus antibodies-time trends and geographical variation. Diabetologia 2005; 48:1280-1287.
77. Viskari HR, Koskela P, Lönnrot M, et al. Can enterovirus infections explain the increasing incidence of type 1 diabetes? Diabetes Care 2000; 23:414-416.
78. Gundersen E. Is diabetes of infectious origin? J Infect Dis 1927; 41:197-202.
79. Hyöty H, Hiltunen M, Reunanen A, et al. Decline of mumps antibodies in Type 1 (insulin-dependent) diabetic children and a plateau in the rising incidence of Type 1 diabetes after introduction of the mumps-measles-rubella vaccine in Finland. Diabetologia 1993; 36:1303-1308.
80. Viskari H, Paronen J, Keskinen P, et al. Humoral beta-cell autoimmunity is rare in patients with the congenital rubella syndrome. Clin Exp Immunol 2003; 133:378-383.
81. Ward KP, Galloway WH, Auchterlonie IA. Congenital cytomegalovirus infection and diabetes. Lancet 1979; 1:497.
82. Ivarsson SA, Lindberg B, Nilsson KO, et al. The prevalence of type 1 diabetes mellitus at follow-up of Swedish infants congenitally infected with cytomegalovirus. Diabetic Med 1993; 10:521-523.
83. Hiltunen M, Hyöty H, Karjalainen J, et al. Serological evaluation of the role of cytomegalovirus in the pathogenesis of IDDM-a prospective study. Diabetologia 1995; 38:705-710.
84. Honeyman MC, Stone NL, Harrison LC. T-cell epitopes in type 1 diabetes autoantigen tyrosine phosphatase IA-2: potential for mimicry with rotavirus and other environmental agents. Mol Med 1998; 4:231-239.
85. Honeyman MC, Coulson BS, Stone NL, et al. Association between rotavirus infection and pancreatic islet autoimmunity in children at risk of developing type 1 diabetes. Diabetes 2000; 49:1319-1324.
86. Blomquist M, Juhela S, Erkkilä S, et al. Rotavirus infections and development of diabetes-associated autoantibodies during the first 2 years of life. Clin Exp Immunol 2002; 128:511-515.
87. Niklasson B, Heller KE, Schonecker B, et al. Development of type 1 diabetes in wild bank voles associated with islet autoantibodies and the novel ljungan virus. Int J Exp Diabesity Res 2003; 4:35-44.
88. Suenaga K, Yoon JW. Association of beta-cell specific expression of endogenous retrovirus with the development of insulitis and diabetes in NOD mice. Diabetes 1988; 37:1722-1726.
89. Hao W, Serreze DV, McCulloch DK, et al. Insulin (auto) antibodies from human IDDM cross-react with retroviral antigen p73. J Autoimmun 1993; 6:787-798.
90. Conrad B, Weissmahr RN, Böni J, et al. A human endogenous retroviral superantigen as candidate autoimmune gene in type 1 diabetes. Cell 1997; 90:303-313.
91. Strachan DP. Hay fever, hygiene and houshold size. Br Med J 1989; 299:1259-1260.
92. Bach JF. The effect of infections on susceptibility to autoimmune and allergic diseases. New Engl J Med 2002; 347:911-920.
93. Gale EAM. The risk of childhood type 1 diabetes in the 20th century. Diabetes 2002; 51:3353-3361.
94. ISAAC Steering Committee. Worldwide variation in the prevalence of asthma, allergic rhino-conjunctivitis and atopic eczema: IAAC. Lancet 1998; 351:1225-1232.
95. Burney PG, Chinn S, Rona RJ. Has the prevalence of asthma increased in children? Evidence from the national study of health and growth 1973-86. Br Med J 1990; 300:1652-1653.
96. Liblau RS, Singer SM, McDevitt HO. Th1 and Th2 CD4p T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol Today 1995; 16:34-38.
97. Berman MA, Sandborg CI, Wang Z, et al. Decreased IL-4 production in new onset type I insulin-dependent diabetes mellitus. J Immunol 1996; 157:4690-4696.
98. Kallman BA, Huther M, Tubes M, et al. Systemic bias of cytokine production toward cell-mediated immune regulation in IDDM and toward humoral immunity in Graves’ disease. Diabetes 1997; 46:237-243.
99. Lowdell M, Bottazzo GF. Autoimmunity and insulin-dependent diabetes. Lancet 1993; 341:1378-1379.
100. Fontenot JD, Rudensky AY. A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3. Nat Immunol 2005; 6:331-337.
101. Sakaguchi S. Naturally arising Foxp3-expressing CD25pCD4p regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 2005; 6:345-352.
102. Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4pCD25p regulatory T cells. Nat Immunol 2003; 4:330-336.
103. Khattri R, Cox T, Yasayko SA, et al. An essential role for Scurfin in CD4pCD25p T regulatory cells. Nat Immunol 2003; 4:337-342.
104. Yagi H, Nomura T, Nakamura K, et al. Crucial role of FOXP3 in the development and function of human CD25pCD4p regulatory T cells. Int Immunol 2004; 16:1643-1656.
105. Walker MR, Kasprowicz DJ, Gersuk VH, et al. Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4pCD25 T cells. J Clin Invest 2003; 112:1437-1443.
106. Rao PE, Petrone AL, Ponath PD. Differentiation and expansion of T cells with regulatory function from human peripheral lymphocytes by stimulation in the presence of TGF-(beta). J Immunol 2005; 174:1446-1455.
107. Belkaid Y, Rouse BT. Natural regulatory T cells in infectious diseases. Nat Immunol 2005; 6:353-360.
108. EURODIAB Substudy 2 Group. Decreased prevalence of atopic diseases in children with diabetes. J Pediatr 2000; 137:470-474.
109. Olesen AB, Juul S, Birkebaek N, et al. Association between atopic dermatitis and insulin-dependent diabetes mellitus: a case-control study. Lancet 2001; 357:1749-1752.
110. von Hertzen LC. Puzzling associations between childhood infections and the later occurrence of asthma and atopy. Ann Med 2000; 32:397-400.
111. McKeever TM, Lewis SA, Smith C, et al. Early exposure to infections and antibiotics and the incidence of allergic disease: a birth cohort study with the West Midlands General Practice Research Database. J Allergy Clin Immunol 2002; 109:43-50.
112. Matricardi PM, Rosmini F, Panetta V, et al. Hay fever and asthma in relation to markers of infection in the United States. J Allergy Clin Immunol 2002; 110:381-387.
113. Rakoff-Nahoum S, Medzhitov R. Role of the innate immune system and hostcommensal mutualism. Curr Top Microbiol Immunol 2006; 308:1-18.
114. Klemola T, Masyuk V, von Hertzen L, et al. Occurrence of atopy among Russian and Finnish schoolchildren. Allergy 2004; 59:465-466.
115. vonHertzen L, Mäkelä MJ, Petäys T, et al.Growing disparities in atopy between the Finns and the Russians: a comparison of two generations. J Allergy Clin Immunol 2006; 117:151-157.
116. Kondrashova A, Viskari H, Romanov A, et al. Signs of b-cell autoimmunity in non-diabetic schoolchildren: a comparison between Russian Karelia with a low incidence of type 1 diabetes and Finland with a high incidence rate. Diabetes Care 2007; 30:95-100.
117. Kondrashova A, Mustalahti K, Kaukinen K, et al. Lower economic status and inferior hygienic environment protect against celiac disease. Ann Med 2007; 39:DO1: 10.1080/07853890701678689.
118. Kondrashova A, Haapala AM, Viskari H, et al. Serological evidence of thyroid autoimmunity among schoolchildren in two different socioeconomic environments. J Clin Endocrinol Metab 2007; 92:in press.
119. Seiskari T, Kondrashova A, Viskari H, et al. Atopic sensitisation and microbial load -a comparison between Finland and Russian Karelia. Clin Exp Immunol 2007; 148:47-52.
120. Viskari H, Salur L, Uibo R, et al. Correlations between the incidence of type 1 diabetes and enterovirus infections in Europe. J Med Virol 2004; 72:610-617.
121. The EURODIAB ACE Study Group and The EURODIAB ACE Substudy 2 Study Group. Familial risk of type I diabetes in European children. Diabetologia 1998; 41:1151-1156.
122. Sadeharju K, Knip M, Hiltunen P, et al. The HLA-DR phenotype modulates the humoral immune response to enterovirus antigens. Diabetologia 2003; 46:1100-1105.
123. Smyth DJ, Cooper JD, Bailey R, et al. A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region. Nat Genet 2006; 38:617-619.
124. Vaarala O, Klemetti P, Juhela S, et al. Effect of coincident enterovirus infection and cow’s milk exposure on immunisation to insulin in early infancy. Diabetologia 2002; 45:531-534.
125. Hagopian W, Lernmark A, Rewers MJ, et al. TEDDY-the environmental determinants of diabetes in the young -an observational clinical trial. Ann N Y Acad Sci 2006; 1079: 320-326.
126. Bingley PJ, Christie MR, Bonifacio E, et al. Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives. Diabetes 1994; 43:1304-1310.
127. Kulmala P, Petersen JS, Vähäsalo P, et al. Prediction of insulin-dependent diabetes mellitus in siblings of diabetic children-a population-based study. J Clin Invest 1998; 101: 327-336.